Fay Kastrinos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fay Kastrinos has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Gregory Idos
17 shared publicationsAaron Grossberg
16 shared publications- Aimee L. Lucas
Division of Gastroenterology and Hepatology, Mount Sinai Morningside and Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, NY
16 shared publications Andrew Lowy
16 shared publications- Bryson William Katona
Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
16 shared publications - Daniel A. Sussman
Division of Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida
16 shared publications
Latest Publications
- 25 August 2026
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 55 (4) , 599-616
Hereditary Pancreatic Cancer
- 25 August 2026
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 55 (4) , 599-616
Hereditary Pancreatic Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 4: Consent and biosample collection rates amongst HRIs stratified by high-risk subgroup
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 4: Consent and biosample collection rates amongst HRIs stratified by high-risk subgroup
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 3: Consent and biosample collection rates amongst HRIs stratified by sex
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 3: Consent and biosample collection rates amongst HRIs stratified by sex
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 1: Comparison of rates of pathogenic variants and cancer history by sex
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 1: Comparison of rates of pathogenic variants and cancer history by sex
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 5: Consent and biosample collection rates amongst HRIs stratified by age
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 5: Consent and biosample collection rates amongst HRIs stratified by age
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 2: Comparison of baseline characteristics of HRIs by site location
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 2: Comparison of baseline characteristics of HRIs by site location
- 24 February 2025
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 23 (10) , 1834-1845.e4
Cost-Effectiveness of Lynch Syndrome Identification Strategies in Individuals With Colorectal Cancer and the Impact on At-Risk Relatives
- 24 February 2025
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 23 (10) , 1834-1845.e4
Cost-Effectiveness of Lynch Syndrome Identification Strategies in Individuals With Colorectal Cancer and the Impact on At-Risk Relatives
- Top Cited PapersOpen Access
- 9 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-7
Impact of population screening for Lynch syndrome insights from the All of Us data
Lynch Syndrome (LS) is a common genetic cancer condition that allows for personalized cancer prevention and early cancer detection in identified gene carriers. We used data from the All of Us (AOU) Research Initiative to assess the prevalence of LS in the general U.S. population, and analyzed demographic, personal, and family cancer history, stratified by LS genotype to compare LS and non-LS carriers. The results suggest that population-based germline testing for LS may identify up to 63.2% of carriers who might remain undetected due to lack of personal or family cancer history. LS affects about 1 in 354 individuals in this U.S. cohort, where pathogenic variants in the genes MSH6 and PMS2 account for the majority of cases. These results underscore the need to optimize the identification of LS across diverse populations and population-based germline testing may capture the most individuals who can benefit from precision cancer screening and prevention.
- 9 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-7
Top Cited PapersOpen AccessImpact of population screening for Lynch syndrome insights from the All of Us data
Lynch Syndrome (LS) is a common genetic cancer condition that allows for personalized cancer prevention and early cancer detection in identified gene carriers. We used data from the All of Us (AOU) Research Initiative to assess the prevalence of LS in the general U.S. population, and analyzed demographic, personal, and family cancer history, stratified by LS genotype to compare LS and non-LS carriers. The results suggest that population-based germline testing for LS may identify up to 63.2% of carriers who might remain undetected due to lack of personal or family cancer history. LS affects about 1 in 354 individuals in this U.S. cohort, where pathogenic variants in the genes MSH6 and PMS2 account for the majority of cases. These results underscore the need to optimize the identification of LS across diverse populations and population-based germline testing may capture the most individuals who can benefit from precision cancer screening and prevention.
- Open Access
- 5 June 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 4: Consent and biosample collection rates amongst HRIs stratified by high-risk subgroup
- 5 June 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 4: Consent and biosample collection rates amongst HRIs stratified by high-risk subgroup
- Open Access
- 5 June 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 3: Consent and biosample collection rates amongst HRIs stratified by sex
- 5 June 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Supplementary Table 3: Consent and biosample collection rates amongst HRIs stratified by sex